Oncology

THREE years after the last in-person European Society for Medical Oncology (ESMO) Congress, the 2022 congress welcomed nearly 23,000 participants in Paris, France, as well as 5,000 online. The purpose of the congress was a celebration of being back together, and of collaboration between all healthcare professionals wanting to improve survival times for patients.

EXPLORING the current state of use of immunotherapies in the treatment of non-small cell lung cancer (NSCLC) and looking to future immunotherapeutic pathways, three expert speakers presented a session at European Society for Medical Oncology (ESMO) Congress 2022, on the 12th of September.

AN INTERNATIONAL COLLECTIVE of oncology clinicians and researchers came together to share the most recent updates in patient care and…

Opening the session, Calvo presented a compelling and balanced case about the potential that Phase 0 (Ph0) trials hold for increasing…

MADRID’S stunning boulevards and awe-inspiring galleries and museums were a sorely-missed backdrop for this year’s European Society…

TRANSFORMATIVE is a term that appropriately describes the striking developments made in the oncology field in recent years. Yet again the…

You have an impressive scientific background, completing a scientific PhD in immunohaematology in addition to your clinical training…

Barcelona, a city with undisputed character, ambience, and beauty, played host this year to the prestigious annual European Society…